Experts offered pointers on appropriate use of iron therapies, erythropoiesis stimulating agents (ESAs), and hypoxia inducible factor inhibitors (HIF-PHI) for anemia of chronic kidney disease (CKD).
Scientists have long been puzzled by how maturing red blood cells manage to produce all the hemoglobin they need to carry ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results